Novalis II General Partner BV
![Novalis II General Partner BV](https://flanders.bio/storage/files/d0d6889a-b6ca-4d28-a016-1d587decbe39/company_novalis-logo-acceleration-02.png)
Ottergemsesteenweg-Zuid 808 Bus B511
9000 Gent
BE
Novalis II General Partner BV
Foundation date
21/08/2017
Sector
#InvestorSubsector
Novalis Biotech seeds biotechnology and life sciences related companies. Novalis develops innovative investment ideas at the early stage and supports further evolution of the companies, by a combination of our contacts, experience and complementary skills.
Our investment ideas focus on the interaction between bio-informatics and life sciences. We strongly believe in applying innovative information technology to advance prevention, diagnosis, or treatment of disease.
Novalis was founded by Prof. Wim Van Criekinge and Jan Van den Berghe.
As an early stage private equity/venture capital fund, we are a dynamic and flexible player not restricting ourselves to specific fields of expertise, but open to discuss any proposition in the field of life-sciences.
Upcoming events
All events-
1109 '24
The Leuven Protein Aggregation Meeting (2nd edition)
Event by: VIB -
1010 '24
-
0411 '24
BIO-Europe® 2024 - 30th Annual International Partnering Conference
Event by: EBD Group
Latest news
More news-
P95 Acquires Assign DMB, Expanding Data Management and Biostatistics Services
Thursday September 5th 2024
Read more
-
reMYND appoints new CEO and Chairman to progress novel Alzheimer’s Disease program through clinical development
Tuesday September 3rd 2024
Read more
-
Biotalys Receives Approval for Large-Scale Demonstration Trials of EVOCA in the Netherlands
Monday September 2nd 2024
Read more
Jobs
More jobs-
-
-
04/09/24
East Flanders
Researcher Formulation and Application @ AmphiStar (Biotope by VIB)
Permanent
VIB
More info?
Ellen Telleir
Communication Coordinator